September 16-18, 2025
Hynes Convention CenterBoston, MAKey Sessions
Kristy Wood
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
Intellia Therapeutics
Ying Cai
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Ultragenyx Pharmaceutical
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
8:55am - 9:00am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
9:00am - 9:30am
Harnessing AI and Machine Learning for the Future of Cell & Gene Therapy Development
- How to effectively adopt AI tools in the CGT space
- Opportunities for AI and machine learning in process development & manufacturing
- Real-world applications of AI in CGT pipeline development
- Case study insights on AI-driven innovation
9:30am - 10:00am
Redosable DNA Delivery Systems Designed by Machine Learning
- Shashi Murthy - CTO and Co-Founder, Nanite Inc.
10:00am - 10:30am
Revolutionizing Targeted Delivery: Emerging Technologies to Enhance Precision & Minimize Off-Target Effects
- Pauline Schmit - Senior Scientist, Preclinical Research, nChroma Bio
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
11:30am - 12:00pm
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
- Kristy Wood - SVP, Technical Operations, Intellia Therapeutics
12:00pm - 12:30pm
Next-Gen Gene Editing – Pushing Boundaries for Enhanced Therapeutics
- Devyn Smith - CEO, Arbor Biotechnologies
12:30pm - 1:00pm
Application of Next Generation Editing Technologies
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
2:15pm - 2:45pm
Case Study from Editas Medicine
- Ratnesh Joshi - Associate Director, Downstream Process Development, Editas Medicine
2:45pm - 3:15pm
Optimizing LNP Delivery and Non-Viral Vector Manufacturing as Scalable, Redosable Alternatives to Viral Vectors
- Weiyi Li - Senior Manager, LNP Formulation, Prime Medicine, Inc.
3:15pm - 3:45pm
Utilizing Next-Gen Delivery Vehicles
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
Showing 1 of 1 Streams
Development of Emerging Cell & Gene Therapies
4:30pm - 5:30pm
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
- Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
- Jeffrey Masten - Senior Vice President CMC, Secretome Therapeutics
- Matthew Provencal - Executive Director Gene Therapy BDS Manufacturing, Sarepta
Filter
Streams
Clear